Therapeutic effect of human umbilical cord mesenchymal stem cells on neonatal rat hypoxic-ischemic encephalopathy

Journal of Neuroscience Research

Volumn 92, Issue 1, 2014, Pages 35-45

  Zhang, Xinhua ^a,b   Zhang, Qinfen ^a   Li, Wei ^c   Nie, Dekang ^b   Chen, Weiwei ^b   Xu, Chunxiang ^a   Yi, Xin ^b   Shi, Jinhong ^b   Tian, Meiling ^b   Qin, Jianbing ^b   Jin, Guohua ^b   Tu, Wenjuan ^a  

^a Changzhou Women and Children's Hospital   (China)

^b NANTONG UNIVERSITY   (China)

^c Jiangsu Beike Biotechnology Ltd   (China)

Author keywords

Ganglioside; Human umbilical cord mesenchymal stem cells; Hypoxic ischemic encephalopathy; Neonatal rats

Indexed keywords

GANGLIOSIDE GM1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOSIS; BRAIN REGION; CONTROLLED STUDY; ENGRAFTMENT; FRONTAL CORTEX; HUMAN; HUMAN CELL; HYPOXIC ISCHEMIC ENCEPHALOPATHY; JUGULAR VEIN; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST; THERAPY EFFECT; UMBILICAL CORD MESENCHYMAL STEM CELL; UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION;

GANGLIOSIDE; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEONATAL RATS;

ANIMALS; CELL DIFFERENTIATION; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MAZE LEARNING; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; UMBILICAL CORD;

EID: 84888035155     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23304     Document Type: Article

References (60)

1. Baldo JV, Shimamura AP. 2002. Frontal lobes and memory. In: Baddeley AD, Kopelman MD, Wilson BA, editors. The handbook of memory disorders. New York: John Wiley & Sons. p 363-379.
2. Bao X, Wei J, Feng M, Lu S, Li G, Dou W, Ma W, Ma S, An Y, Qin C, Zhao RC, Wang R. 2011. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 1367:103-113.
3. Barreto GE, Sun X, Xu L, Giffard RG. 2011. Astrocyte proliferation following stroke in the mouse depends on distance from the infarct. PLoS One 6:e27881.
4. Burra P, Arcidiacono D, Bizzaro D, Chioato T, Di Liddo R, Banerjee A, Cappon A, Bo P, Conconi MT, Parnigotto PP, Mirandola S, Gringeri E, Carraro A, Cillo U, Russo FP. 2012. Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury. BMC Gastroenterol 12:88.
5. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR. 2002. Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 929:252-260.
6. Caplan AI, Dennis JE. 2006. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98:1076-1084.
7. Castelo-Branco MT, Soares ID, Lopes DV, Buongusto F, Martinusso CA, do Rosario A Jr, Souza SA, Gutfilen B, Fonseca LM, Elia C, Madi K, Schanaider A, Rossi MI, Souza HS. 2012. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One 7:e33360.
8. Chang CF, Lin SZ, Chiang YH, Morales M, Chou J, Lein P, Chen HL, Hoffer BJ, Wang Y. 2003. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke 34:558-564.
9. Chen C, Cheng Y, Chen J. 2011. Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats. J Neurosci Res 89:1194-1202.
10. Cho PS, Messina DJ, Hirsh EL, Chi N, Goldman SN, Lo DP, Harris IR, Popma SH, Sachs DH, Huang CA. 2008. Immunogenicity of umbilical cord tissue derived cells. Blood 111:430-438.
11. D'Hooge R, De Deyn PP. 2001. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.
12. Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO, Wall DA. 2001. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant 7:581-588.
13. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. 2008. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 199:587-595.
14. Griffin M, Bhandari R, Hamilton G, Chan YC, Powell JT. 1993. Alveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen. J Cell Sci 105:423-432.
15. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. 2002. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 22:5910-5919.
16. Hedtjarn M, Mallard C, Hagberg H. 2004. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab 24:1333-1351.
17. Jeglinski W, Skup M, Zaremba M, Oderfeld-Nowak B. 1996. Difluoromethylornithine counteracts lesion-induced astrogliosis in rat hippocampus: enhancement of inhibitory effect by combined treatment with GM1 ganglioside. Acta Neurobiol Exp 56:549-553.
18. Jensen MB, Yan H, Krishnaney-Davison R, Al Sawaf A, Zhang SC. 2011. Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J Stroke Cerebrovasc Dis 22:304-308.
19. Kakinuma S, Tanaka Y, Chinzei R, Watanabe M, Shimizu-Saito K, Hara Y, Teramoto K, Arii S, Sato C, Takase K, Yasumizu T, Teraoka H. 2003. Human umbilical cord blood as a source of transplantable hepatic progenitor cells. Stem Cells 21:217-227.
20. Lee JA, Kim BI, Jo CH, Choi CW, Kim EK, Kim HS, Yoon KS, Choi JH. 2010. Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 67:42-46.
21. Lee T. 2012. Stem cell therapy independent of stemness. World J Stem Cells 4:120-124.
22. Leon A, Lipartiti M, Seren MS, Lazzaro A, Mazzari S, Koga T, Toffano G, Skaper SD. 1990. Hypoxic-ischemic damage and the neuroprotective effects of GM1 ganglioside. Stroke 21:III95-III97.
23. Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, Xu W. 2012. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 45:845-854.
24. Li Y, Chopp M. 2009. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett 456:120-123.
25. Lipartiti M, Lazzaro A, Zanoni R, Mazzari S, Toffano G, Leon A. 1991. Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain. Exp Neurol 113:301-305.
26. Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
27. Lotocki G, de Rivero Vaccari JP, Perez ER, Sanchez-Molano J, Furones-Alonso O, Bramlett HM, Dietrich WD. 2009. Alterations in blood-brain barrier permeability to large and small molecules and leukocyte accumulation after traumatic brain injury: effects of post-traumatic hypothermia. J Neurotrauma 26:1123-1134.
28. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC. 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026.
29. Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E, Sipione S. 2010. Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1. J Neurosci 30:4072-4080.
30. Merlo Pich E, Grimaldi R, Zoli M, Biagini G, Solfrini V, Toffano G, Fuxe K, Agnati LF. 1992. Siagoside selectively attenuates morphological and functional striatal impairments induced by transient forebrain ischemia in rats. Stroke 23:234-241.
31. Oderfeld-Nowak B, Jeglinski W, Skup M, Skangiel-Kramska J, Zaremba M, Koczyk D. 1993. Differential effects of GM1 ganglioside treatment on glial fibrillary acidic protein content in the rat septum and hippocampus after partial interruption of their connections. J Neurochem 61:116-119.
32. Ohk TG, Yoo KY, Park SM, Shin BN, Kim I, Park JH, Ahn HC, Lee YJ, Kim MJ, Kim TY, Won MH, Cho JH. 2012. Neuronal damage using fluoro-jade B histofluorescence and gliosis in the striatum after various durations of transient cerebral ischemia in gerbils. Neurochem Res 37:826-834.
33. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
34. Porada CD, Sanada C, Kuo CJ, Colletti E, Mandeville W, Hasenau J, Zanjani ED, Moot R, Doering C, Spencer HT, Almeida-Porada G. 2011. Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC. Exp Hematol 39:1124-1135.
35. Qu CQ, Zhang GH, Zhang LJ, Yang GS. 2007. Osteogenic and adipogenic potential of porcine adipose mesenchymal stem cells. In Vitro Cell Dev Biol Anim 43:95-100.
36. Rao MS, Mattson MP. 2001. Stem cells and aging: expanding the possibilities. Mech Ageing Dev 122:713-734.
37. Rice JE 3rd, Vannucci RC, Brierley JB. 1981. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9:131-141.
38. Romanov YA, Svintsitskaya VA, Smirnov VN. 2003. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105-110.
39. Rosenkranz K, Tenbusch M, May C, Marcus K, Meier C. 2012. Changes in interleukin-1 alpha serum levels after transplantation of umbilical cord blood cells in a model of perinatal hypoxic-ischemic brain damage. Ann Anat 195:122-127.
40. Ryu BR, Choi DW, Hartley DM, Costa E, Jou I, Gwag BJ. 1999. Attenuation of cortical neuronal apoptosis by gangliosides. J Pharmacol Exp Ther 290:811-816.
41. Sasaki Y, Honmou O. 2011. [Bone marrow stem cell therapy for stroke]. Nihon Rinsho 69:2203-2208.
42. Schneider JS, Kean A, DiStefano L. 1995. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice. J Neurosci Res 42:117-123.
43. Schneider JS, Sendek S, Daskalakis C, Cambi F. 2010. GM1 ganglioside in Parkinson's disease: results of a five year open study. J Neurol Sci 292:45-51.
44. Schwartz PH, Massarweh WF, Vinters HV, Wasterlain CG. 1992. A rat model of severe neonatal hypoxic-ischemic brain injury. Stroke 23:539-546.
45. Shi W, Nie D, Jin G, Chen W, Xia L, Wu X, Su X, Xu X, Ni L, Zhang X, Zhang X, Chen J. 2012. BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials 33:3119-3126.
46. Shimamura AP. 2000. The role of the prefrontal cortex in dynamic filtering. Psychobiology 28:207-218.
47. Silveira RC, Procianoy RS. 2003. Interleukin-6 and tumor necrosis factor-alpha levels in plasma and cerebrospinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 143:625-629.
48. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ. 2010. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30:9603-9611.
49. Vannucci RC, Perlman JM. 1997. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 100:1004-1014.
50. Vasiljevic B, Maglajlic-Djukic S, Gojnic M, Stankovic S, Ignjatovic S, Lutovac D. 2011. New insights into the pathogenesis of perinatal hypoxic-ischemic brain injury. Pediatr Int 53:454-462.
51. Wang HW, Lin LM, He HY, You F, Li WZ, Huang TH, Ma GHX, Ma L. 2011. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into insulin-producing cells in vitro. Chin Med J (Engl) 124:1534-1539.
52. Wattanathorn J, Jittiwat J, Tongun T, Muchimapura S, Ingkaninan K. 2011. Zingiber officinale mitigates brain damage and improves memory impairment in focal cerebral ischemic rat. Evidence Based Complement Alternat Med 2011:429505.
53. Wixey JA, Reinebrant HE, Buller KM. 2011. Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain. J Neuropathol Exp Neurol 70:23-35.
54. Xu RX, Yi SY, Wang BY. 1991. Experimental evaluation of blood-brain barrier permeability using colloidal gold particles as tracers in early-stage brain injury. Chin Med J (Engl) 104:634-638.
55. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H, Fu YS. 2008. Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord. PLoS One 3:e3336.
56. Zhang HT, Chen H, Zhao H, Dai YW, Xu RX. 2011. Neural stem cells differentiation ability of human umbilical cord mesenchymal stromal cells is not altered by cryopreservation. Neurosci Lett 487:118-122.
57. Zhang L, Tan X, Dong C, Zou L, Zhao H, Zhang X, Tian M, Jin G. 2012. In vitro differentiation of human umbilical cord mesenchymal stem cells (hUCMSCs), derived from Wharton's jelly, into choline acetyltransferase (ChAT)-positive cells. Int J Dev Neurosci 30:471-477.
58. Zhang ZG, Chopp M. 2009. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol 8:491-500.
59. Zhao W, Li JJ, Cao DY, Li X, Zhang LY, He Y, Yue SQ, Wang DS, Dou KF. 2012. Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. World J Gastroenterol 18:1048-1058.
60. Zhao Z, Chen Z, Zhao X, Pan F, Cai M, Wang T, Zhang H, Lu JR, Lei M. 2011. Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. J Biomed Sci 18:37.